Edwards Lifesciences Corporation (EW)
Largest Insider Buys in Sector
EW Stock Price History Chart
EW Stock Performance
About Edwards Lifesciences Corporation
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides the PASCAL and Cardioband transcatheter valve repair systems for minimally-invasive therapy. In addition, it offers surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; KONECT RESILIA, a pre-assembled aortic tissue valved conduit for patients who require replacement of the valve, root, and ascending aorta; and HARPOON Beating Heart Mitral Valve Repair System for patients with degenerative mitral regurgitation. Further, the company provides critical care solutions, including advanced hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
Insider Activity of Edwards Lifesciences Corporation
Over the last 12 months, insiders at Edwards Lifesciences Corporation have bought $49,753 and sold $35.26M worth of Edwards Lifesciences Corporation stock.
On average, over the past 5 years, insiders at Edwards Lifesciences Corporation have bought $109,049 and sold $76.48M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Zovighian Bernard J (CEO) — $49,753.
The last purchase of 580 shares for transaction amount of $49,753 was made by Zovighian Bernard J (CEO) on 2024‑05‑06.
List of Insider Buy and Sell Transactions, Edwards Lifesciences Corporation
| 2025-01-16 | Sale | CVP,Strategy/Corp Development | 5,000 0.0008% | $68.75 | $343,736 | +1.50% | ||
| 2025-01-16 | Sale | CVP, JAPAC | 500 <0.0001% | $68.76 | $34,382 | +1.48% | ||
| 2024-12-16 | Sale | CVP, JAPAC | 2,500 0.0004% | $74.08 | $185,196 | 0.00% | ||
| 2024-12-09 | Sale | CVP,Strategy/Corp Development | 5,000 0.0009% | $71.75 | $358,751 | +4.17% | ||
| 2024-12-09 | Sale | CVP, Chief Financial Officer | 11,250 0.0019% | $71.68 | $806,406 | +4.17% | ||
| 2024-12-06 | Sale | CVP, TMTT | 1,750 0.0003% | $73.27 | $128,223 | +3.19% | ||
| 2024-12-06 | Sale | GM & SVP, Surgical | 583 0.0001% | $73.27 | $42,716 | +3.19% | ||
| 2024-11-13 | Sale | CVP,Strategy/Corp Development | 5,000 0.0008% | $65.57 | $327,843 | +9.00% | ||
| 2024-11-05 | Sale | Global President TAVR & Surg | 25,000 0.0041% | $65.91 | $1.65M | -0.10% | ||
| 2024-10-15 | Sale | CVP,Strategy/Corp Development | 5,000 0.0009% | $69.51 | $347,534 | +3.11% | ||
| 2024-09-11 | Sale | CVP,Strategy/Corp Development | 5,000 0.0008% | $66.77 | $333,826 | +2.04% | ||
| 2024-08-20 | Sale | CVP, TMTT | 1,250 0.0002% | $69.95 | $87,438 | +0.11% | ||
| 2024-08-14 | Sale | CVP,Strategy/Corp Development | 5,000 0.0008% | $66.08 | $330,420 | 0.00% | ||
| 2024-07-11 | Sale | CVP, JAPAC | 500 <0.0001% | $94.18 | $47,090 | 0.00% | ||
| 2024-07-10 | Sale | CVP,Strategy/Corp Development | 5,000 0.0008% | $93.29 | $466,474 | 0.00% | ||
| 2024-06-20 | Sale | CVP, Chief Financial Officer | 5,625 0.0009% | $87.51 | $492,258 | -21.92% | ||
| 2024-06-20 | Sale | CVP, JAPAC | 535 <0.0001% | $90.00 | $48,150 | -21.92% | ||
| 2024-06-12 | Sale | CVP,Strategy/Corp Development | 5,000 0.0008% | $87.54 | $437,697 | -20.77% | ||
| 2024-05-30 | Sale | CEO | 8,617 0.0014% | $87.68 | $755,539 | -20.35% | ||
| 2024-05-21 | Sale | CVP, Chief Financial Officer | 5,625 0.0009% | $90.45 | $508,803 | -22.37% |
Insider Historical Profitability
| Wood Larry L | Global President TAVR & Surg | 198526 0.0337% | $69.78 | 0 | 100 | |
| Lemercier Jean-Luc M | CVP, EMEACLA and JAPAC | 173849 0.0295% | $69.78 | 0 | 24 | |
| Zovighian Bernard J | CEO | 68218 0.0116% | $69.78 | 1 | 6 | |
| GALLAHUE KIERAN | director | 67219 0.0114% | $69.78 | 2 | 2 | +27.32% |
| BOBO DONALD E JR | CVP,Strategy/Corp Development | 46936 0.008% | $69.78 | 0 | 146 | |
| Szyman Catherine M. | CVP, Critical Care | 34814 0.0059% | $69.78 | 1 | 56 | +31.99% |
| Ullem Scott B. | CVP, Chief Financial Officer | 30561 0.0052% | $69.78 | 0 | 35 | |
| Chopra Daveen | CVP, TMTT | 27583 0.0047% | $69.78 | 0 | 17 | |
| STONE HEISZ LESLIE | director | 26980 0.0046% | $69.78 | 0 | 4 | |
| Lippis Daniel J. | CVP, JAPAC | 23189 0.0039% | $69.78 | 0 | 7 | |
| SELLERS ROBERT W.A. | SVP, Corporate Controller | 13087 0.0022% | $69.78 | 0 | 18 | |
| Markowitz Wayne | GM & SVP, Surgical | 9494 0.0016% | $69.78 | 0 | 1 | |
| MUSSALLEM MICHAEL A | director | 4486 0.0008% | $69.78 | 0 | 239 | |
| Verguet Patrick B | CVP, Europe | 129137 0.0219% | $69.78 | 0 | 91 | |
| KEHL JOHN H JR | CVP, Strategy & Corp Dev | 102839 0.0174% | $69.78 | 0 | 27 | |
| WANG HUIMIN | CVP, Japan & Intercontinental | 99381 0.0168% | $69.78 | 0 | 156 | |
| Cardis John T | director | 91458 0.0155% | $69.78 | 0 | 5 | |
| BOWLIN MICHAEL R | director | 81751 0.0139% | $69.78 | 0 | 10 | |
| VALERIANI NICHOLAS J | director | 63811 0.0108% | $69.78 | 1 | 1 | <0.0001% |
| GARREN BRUCE P | CVP, Public Affairs/Special Co | 62748 0.0106% | $69.78 | 0 | 17 | |
| PYOTT DAVID E I | director | 48429 0.0082% | $69.78 | 1 | 6 | +10.01% |
| MCNEIL BARBARA J | director | 46454 0.0079% | $69.78 | 1 | 5 | +33.89% |
| Abate Thomas M | CVP, CFO | 44393 0.0075% | $69.78 | 0 | 23 | |
| Solomon Carlyn D | CVP, Critical Care & Vascular | 31154 0.0053% | $69.78 | 0 | 18 | |
| INGRAM ROBERT ALEXANDER | director | 30541 0.0052% | $69.78 | 0 | 5 | |
| BESSLER ANITA | CVP | 29410 0.005% | $69.78 | 0 | 7 | |
| NEAL PHILIP M | director | 27333 0.0046% | $69.78 | 0 | 1 | |
| Marsh Martha H. | 26777 0.0045% | $69.78 | 0 | 1 | ||
| LOUCKS VERNON R JR | director | 17106 0.0029% | $69.78 | 0 | 2 | |
| FOSTER STUART L | CVP, Critical Care / Vascular | 17300 0.0029% | $69.78 | 0 | 8 | |
| Nevinny Corinne H | CVP & Pres., Global Ops | 16687 0.0028% | $69.78 | 0 | 13 | |
| Redmond Paul C | CVP, Global Operations | 12534 0.0021% | $69.78 | 0 | 14 | |
| Martin John Alexander | CVP, North America | 11300 0.0019% | $69.78 | 0 | 1 | |
| VON SCHACK WESLEY W | director | 8000 0.0014% | $69.78 | 3 | 6 | +20.17% |
| LORANGER STEVEN R | director | 5000 0.0008% | $69.78 | 1 | 0 | <0.0001% |
| LINK WILLIAM J PHD | director | 4722 0.0008% | $69.78 | 0 | 5 | |
| McCauley Christine Z | CVP, Human Resources | 4234 0.0007% | $69.78 | 0 | 1 | |
| WOODGRIFT RANDEL WILLIAM | Corp VP, Manufacturing Ops | 3349 0.0006% | $69.78 | 0 | 4 | |
| REINDL ROBERT C | CVP, H.R. and Communications | 1124 0.0002% | $69.78 | 0 | 23 |
Institutional Investor Ownership
| The Vanguard Group | $5.06B | 8.79 | 52.96M | +1.15% | +$57.43M | 0.09 | |
| BlackRock | $5.01B | 8.7 | 52.42M | +0.47% | +$23.59M | 0.11 | |
| State Street | $2.56B | 4.44 | 26.78M | -0.67% | -$17.19M | 0.11 | |
| BNY Mellon | $1.81B | 3.15 | 18.97M | +9.49% | +$157.18M | 0.34 | |
| Brown Advisory | $1.59B | 2.76 | 16.64M | -8.5% | -$147.67M | 2.13 | |
| AllianceBernstein | $1.57B | 2.72 | 16.41M | -14.05% | -$256.38M | 0.55 | |
| Wellington Management Company | $1.49B | 2.58 | 15.55M | -7.59% | -$122.1M | 0.25 | |
| Geode Capital Management | $1.25B | 2.17 | 13.09M | +1.76% | +$21.58M | 0.11 | |
| JPMorgan Chase | $914.88M | 1.59 | 9.57M | +23.01% | +$171.13M | 0.08 | |
| Fidelity Investments | $787.37M | 1.37 | 8.24M | +9.83% | +$70.47M | 0.05 | |
| Fisher Asset Management Llc | $728.82M | 1.27 | 7.63M | +7% | +$47.65M | 0.34 | |
| T. Rowe Price | $622.7M | 1.08 | 6.52M | +57.93% | +$228.4M | 0.08 | |
| Morgan Stanley | $590.47M | 1.03 | 6.18M | +1.16% | +$6.78M | 0.04 | |
| Sands Capital | $554.49M | 0.96 | 5.8M | -4.93% | -$28.78M | 1.55 | |
| Northern Trust | $550.94M | 0.96 | 5.77M | -3.14% | -$17.86M | 0.09 | |
| Invesco | $542.62M | 0.94 | 5.68M | +37.88% | +$149.08M | 0.11 | |
| Amundi | $480.1M | 0.92 | 5.52M | -11.41% | -$61.81M | 0.2 | |
| Legal & General | $517.81M | 0.9 | 5.42M | -1.32% | -$6.92M | 0.12 | |
| Janus Henderson | $504.25M | 0.88 | 5.28M | -5.27% | -$28.07M | 0.25 | |
| Winslow Capital Management Llc | $483.41M | 0.84 | 5.06M | New | +$483.41M | 1.82 | |
| Ubs Asset Management Americas Inc | $420.41M | 0.73 | 4.4M | +10.19% | +$38.89M | 0.15 | |
| Wellcome Trust Ltd The As Trustee Of The Wellcome Trust | $391.8M | 0.68 | 4.1M | 0% | +$0 | 4.71 | |
| Deutsche Bank | $347.13M | 0.6 | 3.63M | -6% | -$22.18M | 0.16 | |
| Charles Schwab | $341.59M | 0.59 | 3.57M | +3.65% | +$12.01M | 0.07 | |
| Goldman Sachs | $334.48M | 0.58 | 3.5M | -0.37% | -$1.24M | 0.06 | |
| Holocene Advisors, LP | $324.78M | 0.56 | 3.4M | +285.8% | +$240.59M | 1.2 | |
| Voya Investment Management LLC | $318.39M | 0.55 | 3.33M | +1,088.37% | +$291.6M | 0.35 | |
| Ownership Capital | $308.65M | 0.54 | 3.23M | -7.45% | -$24.84M | 7.06 | |
| Point72 Asset Management | $283.89M | 0.49 | 2.97M | New | +$283.89M | 0.42 | |
| Champlain Investment Partners, LLC | $283.26M | 0.49 | 2.96M | +3.07% | +$8.43M | 1.62 | |
| Cibc Private Wealth Group Llc | $267M | 0.47 | 2.83M | -17.81% | -$57.86M | 0.52 | |
| Royal Bank of Canada | $260.7M | 0.45 | 2.73M | +2.48% | +$6.31M | 0.06 | |
| Citadel Advisors LLC | $252.79M | 0.44 | 2.65M | +764.76% | +$223.56M | 0.15 | |
| Nuveen | $246.47M | 0.43 | 2.58M | -11.2% | -$31.08M | 0.07 | |
| Ameriprise Financial | $235.77M | 0.41 | 2.45M | +34.81% | +$60.87M | 0.07 | |
| AustralianSuper | $229.44M | 0.4 | 2.43M | +10.15% | +$21.14M | 1.34 | |
| Capital International Investors | $211.85M | 0.37 | 2.22M | -75.48% | -$652.16M | 0.04 | |
| Nordea Investment Management Ab | $202.93M | 0.36 | 2.14M | +32.7% | +$50M | 0.24 | |
| The Manufacturers Life Insurance Company | $196.48M | 0.34 | 2.06M | +162.67% | +$121.68M | 0.18 | |
| American Century Investments | $194.92M | 0.34 | 2.04M | -3.62% | -$7.32M | 0.12 | |
| DekaBank | $188.38M | 0.33 | 1.96M | -13.85% | -$30.29M | 0.35 | |
| Bank of America | $182.07M | 0.32 | 1.91M | -32.67% | -$88.33M | 0.02 | |
| PRIMECAP Management Co | $181.66M | 0.32 | 1.9M | 0% | +$0 | 0.13 | |
| Macquarie Group | $178.35M | 0.31 | 1.87M | -6.7% | -$12.8M | 0.16 | |
| Swiss National Bank | $173.57M | 0.3 | 1.82M | -4.46% | -$8.09M | 0.11 | |
| HSBC | $169.67M | 0.3 | 1.78M | +9.85% | +$15.21M | 0.12 | |
| Raymond James Associates | $169.63M | 0.3 | 1.78M | +8.53% | +$13.33M | 0.11 | |
| Railway Pension Investments Ltd | $162.03M | 0.28 | 1.7M | -10.56% | -$19.12M | 1.58 | |
| Credit Suisse | $154.37M | 0.27 | 1.62M | +1.98% | +$2.99M | 0.14 | |
| Sumitomo Mitsui Trust Holdings | $153.84M | 0.27 | 1.61M | +0.41% | +$627,160.28 | 0.1 |